Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

ENDRA Life Sciences (NDRA) FCF Margin (2016 - 2018)

ENDRA Life Sciences has reported FCF Margin over the past 3 years, most recently at 39713.15% for Q1 2018.

  • Quarterly FCF Margin changed N/A to 39713.15% in Q1 2018 from the year-ago period, while the trailing twelve-month figure was 126376.43% through Dec 2018, down 12543767.0% year-over-year, with the annual reading at 126376.43% for FY2018, 12543543.0% down from the prior year.
  • FCF Margin was 39713.15% for Q1 2018 at ENDRA Life Sciences, down from 20081.52% in the prior quarter.
  • Over five years, FCF Margin peaked at 105.93% in Q4 2016 and troughed at 39713.15% in Q1 2018.
  • The 3-year median for FCF Margin is 1977.51% (2017), against an average of 12413.71%.
  • The largest YoY upside for FCF Margin was -1997559bps in 2017 against a maximum downside of -1997559bps in 2017.
  • A 3-year view of FCF Margin shows it stood at 105.93% in 2016, then crashed by -18857bps to 20081.52% in 2017, then plummeted by -98bps to 39713.15% in 2018.
  • Per Business Quant, the three most recent readings for NDRA's FCF Margin are 39713.15% (Q1 2018), 20081.52% (Q4 2017), and 190.46% (Q3 2017).